无坏死或血管增生的表观遗传学定义的异柠檬酸脱氢酶野生型胶质母细胞瘤的生存概率。 - Suppr

Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation.

作者信息

Harter Patrick N, Weber Katharina J, Ricklefs Franz L, Drexler Richard, Schüller Ulrich, Hack Marcel, Hanke Tim, Dohmen Hildegard, Acker Till, von Deimling Andreas, Hasselblatt Martin, Divé Iris, Unger Kristian, Steinbach Joachim P, Capper David, Ronellenfitsch Michael W

机构信息

German Cancer Consortium (DKTK), partner site Munich, a partnership between DKFZ and University/University Hospital, LMU Munich, Munich, Germany.

Faculty of Medicine, Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.

出版信息

Neurooncol Adv. 2024 Aug 2;6(1):vdae138. doi: 10.1093/noajnl/vdae138. eCollection 2024 Jan-Dec.

DOI:10.1093/noajnl/vdae138

PMID:39184173

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11344167/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e088/11344167/8b28f3dfba59/vdae138_fig1.jpg

相似文献

Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation.无坏死或血管增生的表观遗传学定义的异柠檬酸脱氢酶野生型胶质母细胞瘤的生存概率。

Neurooncol Adv. 2024 Aug 2;6(1):vdae138. doi: 10.1093/noajnl/vdae138. eCollection 2024 Jan-Dec.

Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.最大程度切除增强和非增强肿瘤与新诊断胶质母细胞瘤患者分子亚群生存的关联。

JAMA Oncol. 2020 Apr 1;6(4):495-503. doi: 10.1001/jamaoncol.2019.6143.

Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma.初次手术切除和从初次诊断到复发的时间间隔是 IDH 野生型复发性胶质母细胞瘤经手术切除后的独立预后因素。

Clin Neurol Neurosurg. 2020 Sep;196:106006. doi: 10.1016/j.clineuro.2020.106006. Epub 2020 Jun 8.

An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival.一种经独立验证的用于异柠檬酸脱氢酶野生型胶质母细胞瘤患者生存情况的列线图。

Neurooncol Adv. 2019 May-Dec;1(1):vdz007. doi: 10.1093/noajnl/vdz007. Epub 2019 May 30.

Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma.预测 IDH-WT 复发性胶质母细胞瘤对放射外科治疗反应的基因组改变。

J Neurooncol. 2021 Mar;152(1):153-162. doi: 10.1007/s11060-020-03689-0. Epub 2021 Jan 25.

Gyriform infiltration as imaging biomarker for molecular glioblastomas.脑回样浸润作为分子胶质母细胞瘤的影像生物标志物。

J Neurooncol. 2022 May;157(3):511-521. doi: 10.1007/s11060-022-03995-9. Epub 2022 Apr 1.

Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.基于可重复成像的预测，使用结构化报告系统在不同经验水平下对脑胶质瘤的分子亚型和风险分层进行预测。

Eur Radiol. 2021 Oct;31(10):7374-7385. doi: 10.1007/s00330-021-08015-4. Epub 2021 Aug 10.

The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas.异柠檬酸脱氢酶突变在接受同源治疗的间变性星形细胞瘤和胶质母细胞瘤患者中的预后作用。

Acta Neuropathol Commun. 2019 Oct 17;7(1):156. doi: 10.1186/s40478-019-0817-0.

Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent wild-type glioblastoma.激光间质热疗（LITT）治疗新诊断和复发性野生型胶质母细胞瘤的疗效

Neurooncol Adv. 2022 Apr 6;4(1):vdac040. doi: 10.1093/noajnl/vdac040. eCollection 2022 Jan-Dec.

Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis.高级别胶质瘤（IDH 野生型和 IDH 突变型星形细胞瘤，4 级）中最大切除范围与全切除范围对总生存期和无进展生存期的影响：系统评价和荟萃分析。

J Neurooncol. 2023 Aug;164(1):31-41. doi: 10.1007/s11060-023-04409-0. Epub 2023 Aug 10.

本文引用的文献

Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated promoter mutation.缺乏坏死或血管增殖的胶质母细胞瘤：不同的临床表现但结局相似，无论组织学类型或孤立的启动子突变情况如何。

Neurooncol Adv. 2023 Jun 21;5(1):vdad075. doi: 10.1093/noajnl/vdad075. eCollection 2023 Jan-Dec.

DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.DNA 甲基化亚类预测 IDH 野生型胶质母细胞瘤患者从全切除肿瘤中获益。

Neuro Oncol. 2023 Feb 14;25(2):315-325. doi: 10.1093/neuonc/noac177.

Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial.替莫唑胺和放疗联合治疗与单纯放疗在 IDH 野生型胶质母细胞瘤患者中的对比：EORTC 随机 III 期 CATNON 试验的事后分析。

Clin Cancer Res. 2022 Jun 13;28(12):2527-2535. doi: 10.1158/1078-0432.CCR-21-4283.

IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.异柠檬酸脱氢酶野生型低级别弥漫性胶质瘤：组织学分级和分子评估对预后分层的重要性

Neuro Oncol. 2021 Jun 1;23(6):955-966. doi: 10.1093/neuonc/noaa258.

Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma.替莫唑胺治疗 RTK II 甲基化、MGMT 启动子甲基化恶性星形细胞瘤老年患者的优势。

Neuro Oncol. 2020 Aug 17;22(8):1162-1172. doi: 10.1093/neuonc/noaa033.

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".cIMPACT-NOW更新3：“弥漫性星形细胞胶质瘤，IDH野生型，具有胶质母细胞瘤分子特征，WHO四级”的推荐诊断标准。

Acta Neuropathol. 2018 Nov;136(5):805-810. doi: 10.1007/s00401-018-1913-0. Epub 2018 Sep 26.

DNA methylation-based classification of central nervous system tumours.基于 DNA 甲基化的中枢神经系统肿瘤分类。

Nature. 2018 Mar 22;555(7697):469-474. doi: 10.1038/nature26000. Epub 2018 Mar 14.

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.在 Infinium 甲基化 BeadChip 上对胶质母细胞瘤进行 MGMT 甲基化分析，确定了与基因沉默和预后相关的两个不同的 CpG 区域，从而产生了一个预测模型，可用于跨数据集、肿瘤分级和 CIMP 状态进行比较。

Acta Neuropathol. 2012 Oct;124(4):547-60. doi: 10.1007/s00401-012-1016-2. Epub 2012 Jul 19.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献